furosemide has been researched along with ticrynafen in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (37.50) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 1 (6.25) | 29.6817 |
2010's | 8 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bunnell, PR; Crowley, SR; Dodge, PW; Fung, AK; Pariza, RJ; Parks, JA; Pernet, AG; Plattner, JJ | 1 |
Allen, RC; Davis, L; Effland, RC; Kitzen, JM; Novick, WJ; Ranbom, K; Setescak, LL; Shutske, GM; Wilker, JC | 1 |
Cragoe, EJ; Fanelli, GM; Hoffman, WF; Novello, FC; Springer, JP; Watson, LS; Woltersdorf, OW | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Birch, H; Lee, HA; Morgan, A | 1 |
Onodera, T; Takagi, S; Takayama, S | 1 |
de Torrenté, A | 1 |
Berger, L; Kaung, C; Sarkozi, L; Yü, T | 1 |
Masumoto, H; Mitsuru, A; Okazaki, O; Sudo, K; Takakusa, H | 1 |
1 review(s) available for furosemide and ticrynafen
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
15 other study(ies) available for furosemide and ticrynafen
Article | Year |
---|---|
Substituted 5,6-dihydrofuro[3,2-f]-1,2-benzisoxazole-6-carboxylic acids: high-ceiling diuretics with uricosuric activity.
Topics: Animals; Chlorides; Diuretics; Dogs; Dose-Response Relationship, Drug; Furans; Haplorhini; Isoxazoles; Mice; Models, Molecular; Natriuresis; Oxazoles; Potassium; Rats; Sodium; Stereoisomerism; Structure-Activity Relationship; Uricosuric Agents | 1984 |
[(3-aryl-1,2-benzisoxazol-6-yl)oxy]acetic acids. A new diuretic series.
Topics: Animals; Diuretics; Dogs; Isoxazoles; Male; Mice; Oxazoles; Structure-Activity Relationship; Uricosuric Agents | 1982 |
(Acylaryloxy)acetic acid diuretics. 3. 2,3-Dihydro-5-acyl-2-benzofurancarboxylic acids, a new class of uricosuric diuretics.
Topics: Animals; Benzofurans; Chemical Phenomena; Chemistry; Diuretics; Dogs; Pan troglodytes; Rats; Species Specificity; Structure-Activity Relationship; Uricosuric Agents; X-Ray Diffraction | 1981 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.
Topics: Glutathione; Pharmacology; Sulfur Radioisotopes | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
The use of tienilic acid in nephrotic syndrome: a clinical study.
Topics: Adolescent; Adult; Aged; Cholesterol; Female; Furosemide; Glycolates; Humans; Male; Middle Aged; Nephrotic Syndrome; Spironolactone; Ticrynafen; Triglycerides; Uric Acid | 1979 |
Hepatotoxicity of DR-3438, tienilic acid, indacrinone and furosemide studied in vitro.
Topics: Animals; Benzopyrans; Cell Survival; Diuretics; Furosemide; Glutathione; In Vitro Techniques; Indans; Liver; Male; Rats; Ticrynafen | 1991 |
[Tienilic acid, hyperuricemia and kidney function].
Topics: Aged; Creatinine; Female; Furosemide; Glycolates; Heart Failure; Humans; Hydrochlorothiazide; Kidney Function Tests; Male; Middle Aged; Ticrynafen; Uric Acid | 1981 |
Effects of diuretics on urate and calcium excretion.
Topics: Adult; Aged; Calcium; Chlorides; Furosemide; Glycolates; Gout; Humans; Hydrochlorothiazide; Middle Aged; Phosphorus; Potassium; Sodium; Ticrynafen; Uric Acid | 1981 |
Markers of electrophilic stress caused by chemically reactive metabolites in human hepatocytes.
Topics: Acetaminophen; Aspirin; Butylated Hydroxyanisole; Carboxylic Ester Hydrolases; Cells, Cultured; Clozapine; Diclofenac; Furosemide; Glucuronosyltransferase; Heme Oxygenase-1; Hepatocytes; Humans; L-Lactate Dehydrogenase; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; RNA, Messenger; Ticlopidine; Ticrynafen | 2008 |